COc1ccc(-c2[nH]c3c(c2-c2c(-n4cccc4)n(C)c(=O)[nH]c2=O)c(=O)[nH]c(=O)n3C)cc1F
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?